<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33270986</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>22</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1757-4684</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jan</Month><Day>11</Day></PubDate></JournalIssue><Title>EMBO molecular medicine</Title><ISOAbbreviation>EMBO Mol Med</ISOAbbreviation></Journal><ArticleTitle>Machine learning suggests polygenic risk for cognitive dysfunction in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>e12595</StartPage><MedlinePgn>e12595</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e12595</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.15252/emmm.202012595</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a multi-system disease characterized primarily by progressive muscle weakness. Cognitive dysfunction is commonly observed in patients; however, factors influencing risk for cognitive dysfunction remain elusive. Using sparse canonical correlation analysis (sCCA), an unsupervised machine-learning technique, we observed that single nucleotide polymorphisms collectively associate with baseline cognitive performance in a large ALS patient cohort (N&#xa0;=&#xa0;327) from the multicenter Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium. We demonstrate that a polygenic risk score derived using sCCA relates to longitudinal cognitive decline in the same cohort and also to in vivo cortical thinning in the orbital frontal cortex, anterior cingulate cortex, lateral temporal cortex, premotor cortex, and hippocampus (N&#xa0;=&#xa0;90) as well as post-mortem motor cortical neuronal loss (N&#xa0;=&#xa0;87) in independent ALS cohorts from the University of Pennsylvania Integrated Neurodegenerative Disease Biobank. Our findings suggest that common genetic polymorphisms may exert a polygenic contribution to the risk of cortical disease vulnerability and cognitive dysfunction in ALS.</AbstractText><CopyrightInformation>&#xa9; 2020 The Authors. Published under the terms of the CC BY 4.0 license.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Placek</LastName><ForeName>Katerina</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-0832-6684</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benatar</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Leonard M. Miller School of Medicine, University of Miami, Miami, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wuu</LastName><ForeName>Joanne</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Leonard M. Miller School of Medicine, University of Miami, Miami, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rampersaud</LastName><ForeName>Evadnie</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Center for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hennessy</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Deerlin</LastName><ForeName>Vivianna M</ForeName><Initials>VM</Initials><AffiliationInfo><Affiliation>Department of Pathology &amp; Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grossman</LastName><ForeName>Murray</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Irwin</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elman</LastName><ForeName>Lauren</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCluskey</LastName><ForeName>Leo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quinn</LastName><ForeName>Colin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Granit</LastName><ForeName>Volkan</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Neurology, Leonard M. Miller School of Medicine, University of Miami, Miami, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Statland</LastName><ForeName>Jeffrey M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burns</LastName><ForeName>Ted M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Virginia Health System, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ravits</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, University of California San Diego, San Diego, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swenson</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Iowa, Iowa City, IA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katz</LastName><ForeName>Jon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Forbes Norris ALS Center, California Pacific Medical Center, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pioro</LastName><ForeName>Erik P</ForeName><Initials>EP</Initials><AffiliationInfo><Affiliation>Department of Neurology, Cleveland Clinic, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jackson</LastName><ForeName>Carlayne</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Texas Health Science Center, San Antonio, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caress</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>So</LastName><ForeName>Yuen</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Stanford University Medical Center, San Jose, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maiser</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Minnesota Medical Center, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walk</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Minnesota Medical Center, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Edward B</ForeName><Initials>EB</Initials><AffiliationInfo><Affiliation>Department of Pathology &amp; Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trojanowski</LastName><ForeName>John Q</ForeName><Initials>JQ</Initials><AffiliationInfo><Affiliation>Department of Pathology &amp; Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Penn Image Computing Science Laboratory (PICSL), Department of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gee</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Penn Image Computing Science Laboratory (PICSL), Department of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sha</LastName><ForeName>Jin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Penn Neurodegeneration Genomics Center, Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naj</LastName><ForeName>Adam C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Pathology &amp; Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Penn Neurodegeneration Genomics Center, Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rademakers</LastName><ForeName>Rosa</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-4049-0863</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>CReATe Consortium</CollectiveName><AffiliationInfo><Affiliation>Rare Diseases Clinical Research Network, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Wenan</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Center for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Gang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Center for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paul Taylor</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Howard Hughes Medical Institute, Chevy Chase, MS, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McMillan</LastName><ForeName>Corey T</ForeName><Initials>CT</Initials><Identifier Source="ORCID">0000-0002-7581-6405</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG054060</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG017586</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 NS092091</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG066597</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F31 NS106754</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>12</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EMBO Mol Med</MedlineTA><NlmUniqueID>101487380</NlmUniqueID><ISSNLinking>1757-4676</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">cognition</Keyword><Keyword MajorTopicYN="N">frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">polygenic score</Keyword></KeywordList><CoiStatement>The following authors declare the following conflicts of interest: C.T.M. receives financial support from Biogen and has provided consulting for Axon Advisors. M.B. reports grants from National Institutes of Health, the ALS Association, the Muscular Dystrophy Association, the Centers for Disease Control and Prevention, the Department of Defense, and Target ALS during the conduct of the study; personal fees from Mitsubishi Tanabe Pharma, AveXis, Prilenia, Genentech, and Roche outside the submitted work. In addition, M.B. has a provisional patent entitled &#x201c;Determining Onset of Amyotrophic Lateral Sclerosis&#x201d; and serves as a site investigator on clinical trials funded by Biogen and Orphazyme. All other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>10</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>3</Day><Hour>17</Hour><Minute>18</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33270986</ArticleId><ArticleId IdType="pmc">PMC7799365</ArticleId><ArticleId IdType="doi">10.15252/emmm.202012595</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abrahams S, Newton J, Niven E, Foley J, Bak TH (2014) Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener 15: 9&#x2013;14</Citation><ArticleIdList><ArticleId IdType="pubmed">23781974</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F, Ferraro PM, Riva N, Spinelli EG, Chi&#xf2; A, Canu E, Valsasina P, Lunetta C, Iannaccone S, Copetti M et al (2016) Structural brain correlates of cognitive and behavioral impairment in MND. Hum Brain Mapp 37: 1614&#x2013;1626</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6867462</ArticleId><ArticleId IdType="pubmed">26833930</ArticleId></ArticleIdList></Reference><Reference><Citation>Avants BB, Cook PA, Ungar L, Gee JC, Grossman M (2010) Dementia induces correlated reductions in white matter integrity and cortical thickness: a multivariate neuroimaging study with sparse canonical correlation analysis. NeuroImage 50: 1004&#x2013;1016</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2953719</ArticleId><ArticleId IdType="pubmed">20083207</ArticleId></ArticleIdList></Reference><Reference><Citation>Avants BB, Libon DJ, Rascovsky K, Boller A, McMillan CT, Massimo L, Coslett HB, Chatterjee A, Gross RG, Grossman M (2014) Sparse canonical correlation analysis relates network&#x2010;level atrophy to multivariate cognitive measures in a neurodegenerative population. NeuroImage 84: 698&#x2013;711</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3911786</ArticleId><ArticleId IdType="pubmed">24096125</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandres&#x2010;Ciga S, Noyce AJ, Hemani G, Nicolas A, Calvo A, Mora G, ITALSGEN Consortium, International ALS Genomics Consortium , Tienari PJ, Stone DJ et al (2019) Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis. Ann Neurol 85: 470&#x2013;481</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6450729</ArticleId><ArticleId IdType="pubmed">30723964</ArticleId></ArticleIdList></Reference><Reference><Citation>Beeldman E, Raaphorst J, Klein Twennaar M, de Visser M, Schmand BA, de Haan RJ (2016) The cognitive profile of ALS: a systematic review and meta&#x2010;analysis update. J Neurol Neurosurg Psychiatry 87: 611&#x2013;619</Citation><ArticleIdList><ArticleId IdType="pubmed">26283685</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1: 293&#x2013;299</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Burnett B, Li F, Pittman RN (2003) The polyglutamine neurodegenerative protein ataxin&#x2010;3 binds polyubiquitylated proteins and has ubiquitin protease activity. Hum Mol Genet 12: 3195&#x2013;3205</Citation><ArticleIdList><ArticleId IdType="pubmed">14559776</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne S, Elamin M, Bede P, Shatunov A, Walsh C, Corr B, Heverin M, Jordan N, Kenna K, Lynch C et al (2012) Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population&#x2010;based cohort study. Lancet Neurol 11: 232&#x2013;240</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3315021</ArticleId><ArticleId IdType="pubmed">22305801</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, Nakanishi A (1999) The ALSFRS&#x2010;R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 169: 13&#x2013;21</Citation><ArticleIdList><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Crockford C, Newton J, Lonergan K, Chiwera T, Booth T, Chandran S, Colville S, Heverin M, Mays I, Pal S et al (2018) ALS&#x2010;specific cognitive and behavior changes associated with advancing disease stage in ALS. Neurology 91: e1370&#x2013;e1380</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6177274</ArticleId><ArticleId IdType="pubmed">30209236</ArticleId></ArticleIdList></Reference><Reference><Citation>Das S, Forer L, Sch&#xf6;nherr S, Sidore C, Locke AE, Kwong A, Vrieze SI, Chew EY, Levy S, McGue M et al (2016) Next&#x2010;generation genotype imputation service and methods. Nat. Genet. 48: 1284&#x2013;1287</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5157836</ArticleId><ArticleId IdType="pubmed">27571263</ArticleId></ArticleIdList></Reference><Reference><Citation>de Vries BS, Rustemeijer LMM, Bakker LA, Schr&#xf6;der CD, Veldink JH, van den Berg LH, Nijboer TCW, van Es MA (2019) Cognitive and behavioural changes in PLS and PMA:challenging the concept of restricted phenotypes. J Neurol Neurosurg Psychiatry 90: 141&#x2013;147</Citation><ArticleIdList><ArticleId IdType="pubmed">30076267</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus&#x2010;Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J et al (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p&#x2010;linked FTD and ALS. Neuron 72: 245&#x2013;256</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Desikan RS, Schork AJ, Wang Y, Witoelar A, Sharma M, McEvoy LK, Holland D, Brewer JB, Chen C&#x2010;H, Thompson WK et al (2015) Genetic overlap between Alzheimer&#x2018;s disease and Parkinson&#x2019;s disease at the MAPT locus. Mol Psychiatry 20: 1588&#x2013;1595</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4539304</ArticleId><ArticleId IdType="pubmed">25687773</ArticleId></ArticleIdList></Reference><Reference><Citation>Diekstra FP, Van Deerlin VM, van Swieten JC, Al&#x2010;Chalabi A, Ludolph AC, Weishaupt JH, Hardiman O, Landers JE, Brown RH, van Es MA et al (2014) C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: a genome&#x2010;wide meta&#x2010;analysis. Ann Neurol 76: 120&#x2013;133</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4137231</ArticleId><ArticleId IdType="pubmed">24931836</ArticleId></ArticleIdList></Reference><Reference><Citation>Duncan L, Shen H, Gelaye B, Meijsen J, Ressler K, Feldman M, Peterson R, Domingue B (2019) Analysis of polygenic risk score usage and performance in diverse human populations. Nat Commun 10: 3328</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6658471</ArticleId><ArticleId IdType="pubmed">31346163</ArticleId></ArticleIdList></Reference><Reference><Citation>Elamin M, Bede P, Byrne S, Jordan N, Gallagher L, Wynne B, O'Brien C, Phukan J, Lynch C, Pender N et al (2013) Cognitive changes predict functional decline in ALS: a population&#x2010;based longitudinal study. Neurology 80: 1590&#x2013;1597</Citation><ArticleIdList><ArticleId IdType="pubmed">23553481</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari R, Wang Y, Vandrovcova J, Guelfi S, Witeolar A, Karch CM, Schork AJ, Fan CC, Brewer JB, International FTD&#x2010;Genomics Consortium (IFGC) et al (2017) Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer&#x2018;s and Parkinson&#x2019;s diseases. J Neurol Neurosurg Psychiatry 88: 152&#x2013;164.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5237405</ArticleId><ArticleId IdType="pubmed">27899424</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A, Wieland T, Richter B, Ruf W, Schaeffer V, M&#xfc;ller K, Marroquin N, Nordin F, H&#xfc;bers A, Weydt P et al (2015) Haploinsufficiency of TBK1 causes familial ALS and fronto&#x2010;temporal dementia. Nat Neurosci 18: 631&#x2013;636</Citation><ArticleIdList><ArticleId IdType="pubmed">25803835</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannini LAA, Xie SX, McMillan CT, Liang M, Williams A, Jester C, Rascovsky K, Wolk DA, Ash S, Lee EB et al (2019) Divergent patterns of TDP&#x2010;43 and tau pathologies in primary progressive aphasia. Ann Neurol 85: 630&#x2013;643</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6538935</ArticleId><ArticleId IdType="pubmed">30851133</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao X, Li C, Yan J, Yao X, Risacher SL, Saykin AJ, Shen L, Zhang D, Initiative ADN (2017) Identification of associations between genotypes and longitudinal phenotypes via temporally&#x2010;constrained group sparse canonical correlation analysis. Bioinformatics 33: i341&#x2013;i349</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5870577</ArticleId><ArticleId IdType="pubmed">28881979</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu WT, Shelnutt M, Wilson A, Yarab N, Kelly C, Grossman M, Libon DJ, Khan J, Lah JJ, Levey AI et al (2013) Behavior matters&#x2013;cognitive predictors of survival in amyotrophic lateral sclerosis. PLoS One 8: e57584</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3583832</ArticleId><ArticleId IdType="pubmed">23460879</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunt SE, McLaren W, Gil L, Thormann A, Schuilenburg H, Sheppard D, Parton A, Armean IM, Trevanion SJ, Flicek P et al (2018) Ensembl variation resources. Database 2018: 1193</Citation></Reference><Reference><Citation>Irwin DJ, Brettschneider J, McMillan CT, Cooper F, Olm C, Arnold SE, Van Deerlin VM, Seeley WW, Miller BL, Lee EB et al (2016a) Deep clinical and neuropathological phenotyping of Pick disease. Ann Neurol 79: 272&#x2013;287</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4755803</ArticleId><ArticleId IdType="pubmed">26583316</ArticleId></ArticleIdList></Reference><Reference><Citation>Irwin DJ, Byrne MD, McMillan CT, Cooper F, Arnold SE, Lee EB, Van Deerlin VM, Xie SX, Lee VM&#x2010;Y, Grossman M et al (2016b) Semi&#x2010;automated digital image analysis of pick's disease and TDP&#x2010;43 proteinopathy. J Histochem Cytochem 64: 54&#x2013;66</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4810792</ArticleId><ArticleId IdType="pubmed">26538548</ArticleId></ArticleIdList></Reference><Reference><Citation>Irwin DJ, McMillan CT, Suh E, Powers J, Rascovsky K, Wood EM, Toledo JB, Arnold SE, Lee VM&#x2010;Y, Van Deerlin VM et al (2014) Myelin oligodendrocyte basic protein and prognosis in behavioral&#x2010;variant frontotemporal dementia. Neurology 83: 502&#x2013;509</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4141997</ArticleId><ArticleId IdType="pubmed">24994843</ArticleId></ArticleIdList></Reference><Reference><Citation>Irwin DJ, McMillan CT, Xie SX, Rascovsky K, Van Deerlin VM, Coslett HB, Hamilton R, Aguirre GK, Lee EB, Lee VM&#x2010;Y et al (2018) Asymmetry of post&#x2010;mortem neuropathology in behavioural&#x2010;variant frontotemporal dementia. Brain 141: 288&#x2013;301</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5837322</ArticleId><ArticleId IdType="pubmed">29228211</ArticleId></ArticleIdList></Reference><Reference><Citation>Karch CM, Wen N, Fan CC, Yokoyama JS, Kouri N, Ross OA, H&#xf6;glinger G, M&#xfc;ller U, Ferrari R, Hardy J et al (2018) Selective genetic overlap between amyotrophic lateral sclerosis and diseases of the frontotemporal dementia spectrum. JAMA Neurol 75: 1&#x2013;16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6043387</ArticleId><ArticleId IdType="pubmed">29630712</ArticleId></ArticleIdList></Reference><Reference><Citation>Karczewski KJ, Francioli LC, Tiao G, Cummings B, Alfoldi J, Wang Q, Coolins RL, Laricchia KM, Ganna A, Burnbaum D et al (2020) The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581: 434&#x2013;443</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7334197</ArticleId><ArticleId IdType="pubmed">32461654</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenna KP, van Doormaal PTC, Dekker AM, Ticozzi N, Kenna BJ, Diekstra FP, van Rheenen W, van Eijk KR, Jones AR, Keagle P et al (2016) NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. Nat Genet 48: 1037&#x2013;1042</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5560030</ArticleId><ArticleId IdType="pubmed">27455347</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim W&#x2010;K, Liu X, Sandner J, Pasmantier M, Andrews J, Rowland LP, Mitsumoto H (2009) Study of 962 patients indicates progressive muscular atrophy is a form of ALS. Neurology 73: 1686&#x2013;1692</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2788803</ArticleId><ArticleId IdType="pubmed">19917992</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Durbin R (2010) Fast and accurate long&#x2010;read alignment with Burrows&#x2010;Wheeler transform. Bioinformatics 26: 589&#x2013;595</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2828108</ArticleId><ArticleId IdType="pubmed">20080505</ArticleId></ArticleIdList></Reference><Reference><Citation>Lillo P, Mioshi E, Zoing MC, Kiernan MC, Hodges JR (2010) How common are behavioural changes in amyotrophic lateral sclerosis? Amyotrophic Lateral Sclerosis 12: 45&#x2013;51</Citation><ArticleIdList><ArticleId IdType="pubmed">20849323</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippa CF, Rosso AL, Stutzbach LD, Neumann M, Lee VM&#x2010;Y, Trojanowski JQ (2009) Transactive response DNA&#x2010;binding protein 43 burden in familial Alzheimer disease and Down syndrome. Arch Neurol 66: 1483&#x2013;1488</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2864642</ArticleId><ArticleId IdType="pubmed">20008652</ArticleId></ArticleIdList></Reference><Reference><Citation>Lul&#xe9; D, B&#xf6;hm S, M&#xfc;ller H&#x2010;P, Aho&#x2010;&#xd6;zhan H, Keller J, Gorges M, Loose M, Weishaupt JH, Uttner I, Pinkhardt E et al (2018) Cognitive phenotypes of sequential staging in amyotrophic lateral sclerosis. Cortex 101: 163&#x2013;171</Citation><ArticleIdList><ArticleId IdType="pubmed">29477906</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IRA, Neumann M, Baborie A, Sampathu DM, Du Plessis D, Jaros E, Perry RH, Trojanowski JQ, Mann DMA, Lee VM&#x2010;Y (2011) A harmonized classification system for FTLD&#x2010;TDP pathology. Acta Neuropathol. 122: 111&#x2013;113</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3285143</ArticleId><ArticleId IdType="pubmed">21644037</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy S, Das S, Kretzschmar W, Delaneau O, Wood AR, Teumer A, Kang HM, Fuchsberger C, Danecek P, Sharp K et al (2016) A reference panel of 64,976 haplotypes for genotype imputation. Nat Genet 48: 1279&#x2013;1283</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5388176</ArticleId><ArticleId IdType="pubmed">27548312</ArticleId></ArticleIdList></Reference><Reference><Citation>McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M et al (2010) The Genome Analysis Toolkit: a MapReduce framework for analyzing next&#x2010;generation DNA sequencing data. Genome Res 20: 1297&#x2013;1303</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2928508</ArticleId><ArticleId IdType="pubmed">20644199</ArticleId></ArticleIdList></Reference><Reference><Citation>McMillan CT, Toledo JB, Avants BB, Cook PA, Wood EM, Suh E, Irwin DJ, Powers J, Olm C, Elman L et al (2014) Genetic and neuroanatomic associations in sporadic frontotemporal lobar degeneration. Neurobiol Aging 35: 1473&#x2013;1482</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3961542</ArticleId><ArticleId IdType="pubmed">24373676</ArticleId></ArticleIdList></Reference><Reference><Citation>Montuschi A, Iazzolino B, Calvo A, Moglia C, Lopiano L, Restagno G, Brunetti M, Ossola I, Presti Lo A, Cammarosano S et al (2015) Cognitive correlates in amyotrophic lateral sclerosis: a population&#x2010;based study in Italy. J Neurol Neurosurg Psychiatry 86: 168&#x2013;173</Citation><ArticleIdList><ArticleId IdType="pubmed">24769471</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Kwong LK, Lee EB, Kremmer E, Flatley A, Xu Y, Forman MS, Troost D, Kretzschmar HA, Trojanowski JQ et al (2009) Phosphorylation of S409/410 of TDP&#x2010;43 is a consistent feature in all sporadic and familial forms of TDP&#x2010;43 proteinopathies. Acta Neuropathol. 117: 137&#x2013;149</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2693625</ArticleId><ArticleId IdType="pubmed">19125255</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM et al (2006) Ubiquitinated TDP&#x2010;43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314: 130&#x2013;133</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, Dominov JA, Kenna BJ, Nalls MA, Keagle P et al (2018) Genome&#x2010;wide analyses identify KIF5A as a novel ALS gene. Neuron 97: 1268&#x2013;1283</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5867896</ArticleId><ArticleId IdType="pubmed">29566793</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkhomenko E, Tritchler D, Beyene J (2007) Genome&#x2010;wide sparse canonical correlation of gene expression with genotypes. BMC Proc 1(Suppl 1): S119&#x2013;S125</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2367499</ArticleId><ArticleId IdType="pubmed">18466460</ArticleId></ArticleIdList></Reference><Reference><Citation>Placek K, Baer GM, Elman L, McCluskey L, Hennessy L, Ferraro PM, Lee EB, Lee VM&#x2010;Y, Trojanowski JQ, Van Deerlin VM et al (2019) UNC13A polymorphism contributes to frontotemporal disease in sporadic amyotrophic lateral sclerosis. Neurobiol Aging 73: 190&#x2013;199</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6251755</ArticleId><ArticleId IdType="pubmed">30368160</ArticleId></ArticleIdList></Reference><Reference><Citation>Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D (2006) Principal components analysis corrects for stratification in genome&#x2010;wide association studies. Nat Genet 38: 904&#x2013;909</Citation><ArticleIdList><ArticleId IdType="pubmed">16862161</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudlo J, K&#xf6;nig J, Schuster C, Kasper E, B&#xfc;ttner A, Teipel S, Neumann M (2016) TDP&#x2010;43 pathology and cognition in ALS. Neurology 87: 1019&#x2013;1023</Citation><ArticleIdList><ArticleId IdType="pubmed">27488596</ArticleId></ArticleIdList></Reference><Reference><Citation>Purcell S, Neale B, Todd&#x2010;Brown K, Thomas L, Ferreira MAR, Bender D, Maller J, Sklar P, de Bakker PIW, Daly MJ et al (2007) PLINK: a tool set for whole&#x2010;genome association and population&#x2010;based linkage analyses. Am. J. Hum. Genet. 81: 559&#x2013;575</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1950838</ArticleId><ArticleId IdType="pubmed">17701901</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, Sim&#xf3;n&#x2010;S&#xe1;nchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L et al (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21&#x2010;linked ALS&#x2010;FTD. Neuron 72: 257&#x2013;268</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59&#x2013;62</Citation><ArticleIdList><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon N, Goldstein LH (2019) Screening for cognitive and behavioral change in amyotrophic lateral sclerosis/motor neuron disease: a systematic review of validated screening methods. Amyotroph Lateral Scler Frontotemporal Degener 20: 1&#x2013;11</Citation><ArticleIdList><ArticleId IdType="pubmed">30585510</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith SM, Nichols TE (2009) Threshold&#x2010;free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. NeuroImage 44: 83&#x2013;98</Citation><ArticleIdList><ArticleId IdType="pubmed">18501637</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong MJ, Abrahams S, Goldstein LH, Woolley S, Mclaughlin P, Snowden J, Mioshi E, Roberts&#x2010;South A, Benatar M, Hortob&#xe1;gyi T et al (2017) Amyotrophic lateral sclerosis &#x2010; frontotemporal spectrum disorder (ALS&#x2010;FTSD): revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener 18: 1&#x2013;22</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7409990</ArticleId><ArticleId IdType="pubmed">28054827</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugrue LP, Desikan RS (2019) What are polygenic scores and why are they important? JAMA 321: 1820&#x2013;1821</Citation><ArticleIdList><ArticleId IdType="pubmed">30958510</ArticleId></ArticleIdList></Reference><Reference><Citation>Suh E, Lee EB, Neal D, Wood EM, Toledo JB, Rennert L, Irwin DJ, McMillan CT, Krock B, Elman LB et al (2015) Semi&#x2010;automated quantification of C9orf72 expansion size reveals inverse correlation between hexanucleotide repeat number and disease duration in frontotemporal degeneration. Acta Neuropathol. 130: 1&#x2013;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4545720</ArticleId><ArticleId IdType="pubmed">26022924</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan A, Abecasis GR, Kang HM (2015) Unified representation of genetic variants. Bioinformatics 31: 2202&#x2013;2204</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4481842</ArticleId><ArticleId IdType="pubmed">25701572</ArticleId></ArticleIdList></Reference><Reference><Citation>Toledo JB, Van Deerlin VM, Lee EB, Suh E, Baek Y, Robinson JL, Xie SX, McBride J, Wood EM, Schuck T et al (2014) A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank. Alzheimers Dement 10: 477&#x2013;84</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3933464</ArticleId><ArticleId IdType="pubmed">23978324</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Al&#x2010;Chalabi A, Chi&#xf2; A, Hardiman O, Kiernan MC, Rohrer JD, Rowe J, Seeley W, Talbot K (2017) Genetic screening in sporadic ALS and FTD. J Neurol Neurosurg Psychiatry 88: 1042&#x2013;1044</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5740553</ArticleId><ArticleId IdType="pubmed">28642287</ArticleId></ArticleIdList></Reference><Reference><Citation>Tustison NJ, Avants BB, Cook PA, Zheng Y, Egan A, Yushkevich PA, Gee JC (2010) N4ITK: improved N3 bias correction. IEEE Trans Med Imaging 29: 1310&#x2013;1320</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3071855</ArticleId><ArticleId IdType="pubmed">20378467</ArticleId></ArticleIdList></Reference><Reference><Citation>Tustison NJ, Cook PA, Klein A, Song G, Das SR, Duda JT, Kandel BM, van Strien N, Stone JR, Gee JC et al (2014) Large&#x2010;scale evaluation of ANTs and FreeSurfer cortical thickness measurements. NeuroImage 99: 166&#x2013;179</Citation><ArticleIdList><ArticleId IdType="pubmed">24879923</ArticleId></ArticleIdList></Reference><Reference><Citation>Umoh ME, Fournier C, Li Y, Polak M, Shaw L, Landers JE, Hu W, Gearing M, Glass JD (2016) Comparative analysis of C9orf72 and sporadic disease in an ALS clinic population. Neurology 87: 1024&#x2013;1030</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5027809</ArticleId><ArticleId IdType="pubmed">27488601</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Deerlin VM, Leverenz JB, Bekris LM, Bird TD, Yuan W, Elman LB, Clay D, Wood EM, Chen&#x2010;Plotkin AS, Martinez&#x2010;Lage M et al (2008) TARDBP mutations in amyotrophic lateral sclerosis with TDP&#x2010;43 neuropathology: a genetic and histopathological analysis. Lancet Neurol 7: 409&#x2013;416</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3546119</ArticleId><ArticleId IdType="pubmed">18396105</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es MA, Veldink JH, Saris CGJ, Blauw HM, van Vught PWJ, Birve A, Lemmens R, Schelhaas HJ, Groen EJN, Huisman MHB et al (2009) Genome&#x2010;wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat. Genet. 41: 1083&#x2013;1087</Citation><ArticleIdList><ArticleId IdType="pubmed">19734901</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rheenen W, Shatunov A, Dekker AM, McLaughlin RL, Diekstra FP, Pulit SL, van der Spek RAA, V&#xf5;sa U, de Jong S, Robinson MR et al (2016) Genome&#x2010;wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat. Genet. 48: 1043&#x2013;1048</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5556360</ArticleId><ArticleId IdType="pubmed">27455348</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C, Rogelj B, Hortob&#xe1;gyi T, De Vos KJ, Nishimura AL, Sreedharan J, Hu X, Smith B, Ruddy D, Wright P et al (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323: 1208&#x2013;1211</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Vass R, Ashbridge E, Geser F, Hu WT, Grossman M, Clay&#x2010;Falcone D, Elman L, McCluskey L, Lee VM&#x2010;Y, Van Deerlin VM et al (2011) Risk genotypes at TMEM106B are associated with cognitive impairment in amyotrophic lateral sclerosis. Acta Neuropathol. 121: 373&#x2013;380</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3095217</ArticleId><ArticleId IdType="pubmed">21104415</ArticleId></ArticleIdList></Reference><Reference><Citation>Wald NJ, Old R (2019) The illusion of polygenic disease risk prediction. Genet Med 21: 1705&#x2013;1707</Citation><ArticleIdList><ArticleId IdType="pubmed">30635622</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler AM, Ridgway GR, Webster MA, Smith SM, Nichols TE (2014) Permutation inference for the general linear model. NeuroImage 92: 381&#x2013;397</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4010955</ArticleId><ArticleId IdType="pubmed">24530839</ArticleId></ArticleIdList></Reference><Reference><Citation>Witten DM, Tibshirani RJ (2009) Extensions of sparse canonical correlation analysis with applications to genomic data. Stat Appl Genet Mol Biol 8: 28</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2861323</ArticleId><ArticleId IdType="pubmed">19572827</ArticleId></ArticleIdList></Reference><Reference><Citation>Witten DM, Tibshirani R, Hastie T (2009) A penalized matrix decomposition, with applications to sparse principal components and canonical correlation analysis. Biostatistics 10: 515&#x2013;534</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2697346</ArticleId><ArticleId IdType="pubmed">19377034</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood EM, Falcone D, Suh E, Irwin DJ, Chen&#x2010;Plotkin AS, Lee EB, Xie SX, Van Deerlin VM, Grossman M (2013) Development and validation of pedigree classification criteria for frontotemporal lobar degeneration. JAMA Neurol 70: 1411&#x2013;1417</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3906581</ArticleId><ArticleId IdType="pubmed">24081456</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia CH, Ma Z, Ciric R, Gu S, Betzel RF, Kaczkurkin AN, Calkins ME, Cook PA, Garc&#xed;a de la Garza A, Vandekar SN et al (2018) Linked dimensions of psychopathology and connectivity in functional brain networks. Nat Commun 9: 1&#x2013;14</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6070480</ArticleId><ArticleId IdType="pubmed">30068943</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokoyama JS, Karch CM, Fan CC, Bonham LW, Kouri N, Ross OA, Rademakers R, Kim J, Wang Y, H&#xf6;glinger GU et al (2017) Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia. Acta Neuropathol. 133: 825&#x2013;837</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5429027</ArticleId><ArticleId IdType="pubmed">28271184</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>